RightFit
Not yet recruitingNot applicable

Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
15 Years to 25 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests RESTEPS, an 8-session mental health program for young people ages 15–25 with early psychosis and past or current suicidal thoughts or actions. Psychosis can make it hard to tell what is real. The program aims to lower suicide risk by addressing shame and unfair treatment linked to mental illness and building social support.

We will develop a mental health program, called RESTEPS, for patients with early psychosis being treated in outpatient mental health centers, focusing on reducing suicide risk by targeting mental health stigma and social support. Youth (n = 35) with psychosis and current/past suicidal thoughts or behaviors will be recruited from community mental health centers to complete an initial open trial examining the feasibility and acceptability of RESTEPS, an 8-session intervention. Participants will be assessed at baseline, mid-intervention, post-intervention, and at a 6-month follow-up.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be 15–25 years old.
  • Have a schizophrenia-related disorder, or depression or bipolar disorder with psychosis, confirmed through a study interview.
  • Have had psychosis symptoms for less than 2 years, OR be getting care at an early psychosis or first-episode psychosis clinic.
  • Have had suicidal thoughts or made a suicide attempt at any time in your life.
  • If younger than 18, have a parent, guardian, or significant other willing to take part.
  • Be able to speak and read English well enough to complete study tasks.

Who can't join

  • Psychosis symptoms caused only by being under the influence of alcohol or drugs, withdrawal, or a known medical condition. Other substance use disorders are allowed.
  • Current psychosis symptoms so severe that you cannot agree to take part or complete study tasks.
  • Being in a hospital against your will when asked to agree to join the study.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1) 15-25 years of age; 2) schizophrenia-spectrum disorder diagnosis (e.g., schizophreniform, schizoaffective disorder, schizophrenia, delusional disorder) or mood disorder with psychotic features (e.g., major depressive disorder with psychotic features, bipolar disorder with psychotic features) confirmed via Structured Clinical Interview for the DSM-5; 3) positive psychotic symptom duration of \< 2 years OR currently receiving treatment in an early psychosis or first-episode psychosis clinic. 4) Suicide risk defined as any lifetime suicide attempt or suicidal ideation (yes to Questions 1, 2, 3, 4, or 5 on the Columbia Suicide Severity Rating Scale or C-SSRS); 4) for participants younger than 18 only, parent/guardian significant other willing to participate in the study; 5) ability to speak and read English sufficiently to complete study procedures. Exclusion Criteria: 1) psychotic symptoms due solely to substance intoxication or withdrawal (otherwise, comorbid substance use disorders will be allowed) or a known medical condition; 2) severe current psychotic symptoms preventing the participant from providing informed consent/assent and/or being able to engage in the study procedures; or 3) involuntary hospital at the time of consent.

Study sites (1)

RI